Vaccine

Article	Citations
Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)	284
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	184
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	174
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	130
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirköy strain sheep pox vaccine under field conditions	127
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	105
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	103
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	101
Erratum to “Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals” [Vaccine 41(37) (2023) 5469-5476]	101
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study	91
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation	89
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	88
Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus	87
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	86
Nationwide rollout of HPV vaccination in Nepal: Early key insights	82
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine	81
Editorial Board/Aims and Scope	75
Editorial Board/Aims and Scope	74
Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus	70
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	69
The Brucella abortus A19ΔfeuPΔfeuQ double-mutant is highly attenuated and confers protection in BALB/c mice	68
Advancing the use of vaccine impact modeling for immunization decisions in low- and middle-income countries	66
Examining the independent and interactive roles of intolerance of uncertainty in vaccination intent	62
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	61
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea	61

Racial and ethnic differences among Mpox vaccination recipients by vaccination facility type in New York City—August–December 2022	61
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study	59
Corrigendum to “Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge” [Vaccine 61 (2025) 127347]	58
Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides	58
Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study	57
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971	57
Corrigendum to “I want to chat with a person”: a qualitative longitudinal cohort study in England exploring drivers of sub-optimal childhood vaccination uptake” [Vaccine 62 (2025) 127462]	57
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	56
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2	55
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	55
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	53
A scoping review of multicomponent interventions to improve uptake of routine childhood vaccines in low- and middle-income countries	51
Pneumococcal vaccines: A dose of change. Vaccine failures and breakthrough infections in Belgian children during the PCV13 era (2019–2024)	49
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	49
COVID-19 vaccine production and the technological gap in the Global South: The cases of Argentina and Brazil	49
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	48
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years an	46
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	46
Multi-mode spatial accessibility to vaccination services and its impact on influenza-related hospitalisations among older adults	46
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019	45
IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route	45
Assessing vaccination intentions and perceptions among pregnant women in Italy: A multicenter cross-sectional study in the context of mandatory policies and the COVID-19 pandemic	44
Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vac	44
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England	43
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	42
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	41
Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness—IVY network, January 24, 2022–September 1, 2024	41
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs	41
Corrigendum to “A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme” [Vaccine 42(20) (2024) 125988	41
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	40
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-con	40
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling	40
A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge	40
Determinants of immunization in polio super high-risk union councils of Pakistan	40
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States	40
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	39
Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate	39
Immunogenicity and safety of Sabin-strain inactivated poliovirus vaccine in infants: a systematic review and meta-analysis	39
Analysis of HPV vaccination and influencing factors among 9–14-year-old girls in underdeveloped areas of northwestern China: A cross-sectional survey report on guardians	39
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation	39
Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England	39
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents	38
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination	38
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	38
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic	38
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	37
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants	37
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	36
Vaccine misinformation among Arabic-speakers in Australia and the audience and appetite for a game-based intervention	36
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	36

Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	35
Weaving a public health network: Process and results from an evaluation of CDC’s Prevention Research Centers Vaccine Confidence Network	35
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	35
Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study	35
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	34
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women	34
Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal models	34
A modified self-controlled case series on mortality risk following primary series doses of COVID-19 vaccines in U.S. Medicare beneficiaries aged 65 years and older	33
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	33
Systematic review of pro-equity strategies to improve vaccination among priority populations	33
The U.S. COVID-19 vaccination program: A look back and future directions	32
Measles seroprevalence among individuals serologically tested in Ontario, Canada	32
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states	32
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)	32
Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series	32
BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy	32
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	31
Collateral damage from debunking mRNA vaccine misinformation	31
Characteristics of reported mumps cases in the United States: 2018–2023	31
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the fi	31
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations	31
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink	31
State minor consent laws and human papilloma virus vaccine uptake: An analysis of the 2023 National Immunization Survey-Teen Data	31
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	30
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families li	30
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	30
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines	30
Effectiveness of the varicella vaccine in the real world, a matched case-control study	30
The social lives of the SARS-CoV-2 vaccines: A qualitative study of vaccine understandings and decision-making among people of Black ethnicities in London, UK	30
Dropout from the pentavalent vaccine series among children aged 12–23 months in the Central African Republic: prevalence, associated factors, and caregiver-reported barriers	30
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	30
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	30
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination	30
Immunogenicity of 2 versus 3 dose HPV vaccination by HIV infection status in Eswatini	30
Immunogenicity and safety of Papilloguard® 4, the first quadrivalent HPV vaccine combined with adjuvant system 04, versus Gardasil® in healthy 15–25-year-old individuals: a phase III, randomized, doub	29
Booster vaccine reduces BCG-primed mice's protection against primary Mycobacterium tuberculosis infection by raising IL-10 levels	29
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2	29
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	29
A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023	29
Natural direct effects of vaccines and post-vaccination behaviour	29
Bivalent foot-and-mouth disease virus mRNA vaccine induces well-balanced humoral and cellular immune responses	29
Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages	29
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	28
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	28
Public health impact and cost-effectiveness of implementing a ‘pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico	28
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine	28
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants	28
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	28
Prioritizing the introduction of new vaccine in Tanzania (2026–2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group	28
Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo	28
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	28
Consultation report - gonococcal immunoassays and standards for vaccine development	28
Editorial Board	28
Role of civil society organisations in immunisation: A scoping review	28
Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China	27
Genetic and molecular basis for low efficacy of vaccine strains against canine distemper virus in Brazil	27
Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community	27
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study	27
Strategies to improve interprofessional communication regarding maternal and infant RSV immunization	27
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles	27
New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada	27
COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan	27
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster	27
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged	27
Vaccine value profile for Salmonella enterica serovar Paratyphi A	27
Documenting human papillomavirus vaccine refusal among adolescents in electronic health records: A mixed methods study	26
Using latent class analysis of survey data to explore parent behaviors and attitudes regarding children's COVID vaccinations	26
Harmonized case definitions for endpoints in vaccine efficacy trials are needed	26
Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model	26
Editorial Board	26
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022	26
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers	26
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study	26
Analyzing attitudes toward COVID-19 vaccine decision making among pregnant women in Pakistan	26
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents	26
The relationship between state vaccination exemption policies and MMR vaccination trends in the U.S.	26
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021	26
Engineered flagellin-based adjuvant boosts mucosal immunity in recombinant RSV vaccine	26
Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission	26
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students	26

Safe and efficacious inactivated immersion vaccine against KG+ phenotype of emerging bacterial pathogen Lactococcus garvieae for early developmental stage of rainbow trout (Oncorhynchus mykiss) in Ind	26
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6–23 months in Kenya: 2019–2021	26
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET	25
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020	25
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients	25
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)	25
Crowdfunding narratives and the valuation of vaccines for COVID-19	25
Editorial Board/Aims and Scope	25
Editorial Board/Aims and Scope	25
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial	25
Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observat	24
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan	24
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan	24
Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion	24
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella	24
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) S	24
Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents	24
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs	24
Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children	24
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates	24
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial	24
COVID-19 hoax belief endorsement and its implications for vaccine uptake: Investigating the role of perceived threat	24
Influenza vaccination status ascertainment and vaccine effectiveness estimation: Validity of self-report for current and prior season	24
Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data	24
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022	24
Evaluation of anti-Pertussis antibody levels in Iranian infants and children: Is it time to include booster acellular Pertussis Vaccines in the immunization schedule?	24
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer	24
Vaccine candidate based on a baculovirus expressed VP2 provides full protection from epizootic hemorrhagic disease virus serotype 8 in calves	24
Enhancing NA immunogenicity through novel VLP designs.	24
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study	23
Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy	23
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children	23
Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Côte d’Ivoire	23
High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV	23
Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib)	23
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic	23
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina	23
ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation	23
Accuracy of self-reported vaccination status using surveys in safety-net, integrated and rural health systems in Colorado	23
COVID-19 vaccine decision-making among Black women: A qualitative study	23
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study	23
Post-vaccination fever in infants: Real-world data analysis using a childcare mobile application	22
Corrigendum to “Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III tria	22
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study	22
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development	22
Drivers of decision-making for future adult vaccines: a best–worst scaling among community members and health care workers in Zambia	22
Factors associated with vaccination intention and uptake over time in a sample of older Australians	22
Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia	22
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system	22
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]	22
The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III	22
Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster	22
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-s	22
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets	22
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs t	22
Weighing the risks and benefits: Parental perspectives on COVID-19 vaccines for 5- to 11-year-old children	22
Corrigendum to “Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurell	22
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine	22
Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities	22
Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1	22
Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults	22
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adu	22
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis	21
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate	21
A phase 3 randomized trial (STRIDE-9) to evaluate the safety, tolerability, and immunogenicity of V116, a population-specific pneumococcal conjugate vaccine, in pneumococcal vaccine-naïve Japanese adu	21
Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine	21
The shadow of reactogenicity: Parental hesitancy due to prior vaccine experiences	21
County-level correlates of completed HPV vaccination in Indiana	21
How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?	21
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for	21
How manufacturing won or lost the COVID-19 vaccine race	21
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks	21
Consultation report – considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries	21
HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review	21
Safety of the adjuvanted herpes zoster subunit vaccine in people over 18 years of age living with HIV: A phase 4 multicentre study	21
Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity	21
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia	21
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens	21
Impact of electronic immunization registries and electronic logistics management information systems in four low-and middle-income countries: Guinea, Honduras, Rwanda, and Tanzania	21
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study	21
Determinants of COVID-19 vaccine hesitancy and resistance in Russia	21
Vaccines against Neisseria meningitidis serogroup B strains – What does genomics reveal on the Portuguese strain’s coverage	21
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection	21
Structural determinants of vaccine access: an integrated review of the Canadian literature	21
Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus	21
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain	21
Evaluation of Rift Valley fever vaccine candidates in pregnant rodent models	21
The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review	21
From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis	20
Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice models	20
Adjuvant-free pH-controlled aggregates of E. coli–expressed H1N1-RBD enhance neutralizing antibody responses and confer protection against influenza virus	20
Australian adults' views on influenza vaccination: Implications for communication and service quality from a qualitative study	20
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS‐Cov-2 B.1.1.529 (Omicron) variant	20
Corrigendum to “Breastfeeding women’s attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research” [Vaccine 41 (2023) 1198–1208]	20
Editorial Board	20